The Next Stage of COVID-19 Vaccine Roll-Out in United States: Children Under 12
Analysis of characteristics of children under 12 in the U.S. to help inform COVID-19 vaccination efforts when they become eligible.
View the Latest: Children
Filter
-
-
KFF COVID-19 Vaccine Monitor: The Impact Of The Coronavirus Pandemic On The Wellbeing Of Parents And Children
Poll FindingThis report examines the impact of the COVID-19 pandemic on the wellbeing of parents and children. It finds that more than one-third of parents say their child fell behind academically or in their social and emotional development as a result of the pandemic. This report also examines the mental health and wellbeing of parents whose household experienced an employment disruption due to childcare needs and of children who attended school at least partially online.
-
Parents Report More Negative Pandemic Effects on Kids Who Attend School Virtually vs. In-Person
From Drew AltmanIn his latest Axios column, Drew Altman shows that parents feel that children have fared better during COVID attending school in-person than virtually in terms of academic performance and their mental health and wellbeing.
-
Racial Disparities in COVID-19 Impacts and Vaccinations for Children
Issue BriefCOVID-19 has disproportionately negatively affected the physical and mental health, academic growth, and economic security of children of color. At the same time, the limited data available to date suggest some children of color may be less likely to receive a COVID-19 vaccine, leaving them at elevated risk as the virus continues to spread and as many return to in-person school.
-
KFF COVID-19 Vaccine Monitor: Vaccination Trends Among Children And COVID-19 In Schools
Poll FindingThis report tracks parents' vaccine COVID-19 vaccine intentions for their children and finds that nearly half of parents of 12-17 year olds say their child has already gotten the COVID-19 vaccine. This report also examines parents' views on school policies and precautions to limit the spread of COVID-19 and keep children safe.
-
Analysis Examines How States Can Use Medicaid Programs to Facilitate Access to Vaccines for Low-Income Children
News ReleaseAs states expand COVID-19 vaccination efforts to reach newly eligible children ages 5 to 11, a new KFF analysis highlights several tools state Medicaid programs have at their disposal to increase access to, and take up of, vaccines among lower-income children.
-
Following an Early Period of High Demand, Vaccination for Children Ages 5-11 Has Significantly Slowed
News ReleaseAs of December 5, 16.7% of 5-11 year-olds had received at least one COVID-19 vaccine dose with 4.3% of children reaching full vaccination, according to a new KFF analysis.
-
KFF COVID-19 Vaccine Monitor: Winter 2021 Update On Parents’ Views Of Vaccines For Kids
Poll FindingThis report updates parents' intentions for vaccinating their children, against COVID-19, as well as their views and concerns about vaccine safety, whether their schools encourage vaccination, and how the pandemic has affected their children, mental health, and ability to afford necessities.
-
Medicaid Enrollment Churn and Implications for Continuous Coverage Policies
Issue BriefRecent policy actions and proposals in Medicaid have renewed focus on the problem of churn, or temporary loss of coverage in which enrollees disenroll and then re-enroll within a short period of time. We find that 10% of full-benefit enrollees have a gap in coverage of less than a year, and rates are higher for children and adults compared to aged and people with disabilities. Churn has implications for access to care as well as administrative costs faced by states.
-
Half of Parents of Adolescents 12-17 Say Their Child Has Gotten a COVID-19 Vaccine, though Uptake Has Slowed; 16% of Parents of 5-11 Year-olds Say Their Child Has Gotten a Vaccine
News ReleaseCOVID-19 vaccine uptake among adolescents ages 12-17 has slowed after an initial wave of enthusiasm over the summer, with half (49%) of parents saying their adolescent has received at least one dose, a new KFF COVID-19 Vaccine Monitor report reveals. The share is little changed since earlier in the fall.